Good news for GlaxoSmithKline Plc. (GSK). U.S. District Judge Joel Pisano ruled yesterday that the pharmaceutical giant has the right to sell an authorized copy of its antidepressant Paxil CR to Canadian pharmaceutical company Apotex Inc.
Generic drug company Mylan Inc. filed suit against GSK in October 2010 for breach of contract, claiming that GSK violated the terms of a licensing agreement by working with Apotex to sell a Paxil copy. Mylan and GSK had signed a two-year agreement in 2008 to market a copy of the drug.